Rafferty Emily Ann

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rafferty Emily Ann's trades of Evolent Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
436.02
Quantity 27,825 -11.2%
Value US$768,762
Transaction date
Proposed sale
Price
87.32
Quantity 17,617
Value US$4,172,088
Transaction date
Sale
Price
371.14
Quantity 24,836 -29.9%
Value US$2,872,273
Transaction date
Proposed sale
Price
27.71
Quantity 7,900
Value US$218,928
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-26 2024-08-22
PlS Planned sale
27,825 -11.2%
436.02
US$768,762 		27,825 -11.2% 436.02 US$768,762
2024-08-22 2024-08-22
PrS Proposed sale
17,617
87.32
US$4,172,088 		17,617 87.32 US$4,172,088
2023-08-17 2023-08-15
S Sale
24,836 -29.9%
371.14
US$2,872,273 		24,836 -29.9% 371.14 US$2,872,273
2023-08-15 2023-08-15
PrS Proposed sale
7,900
27.71
US$218,928 		7,900 27.71 US$218,928